secwatch.observer — SEC 8-K summary
======================================

Issuer:     TENAX THERAPEUTICS, INC. (TENX)
CIK:        0000034956
Form:       8-K
Filed at:   2022-06-16T23:59:59+00:00
Accession:  0001654954-22-008452
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Two Armistice Capital directors resign from Tenax board; Armistice waives appointment right
--------------------------------------------------------------------------------

- Steven Boyd and Keith Maher resigned from Tenax board effective June 10, 2022; no disagreement cited.
- Boyd and Maher were designees of Armistice Capital Master Fund Ltd., which had right to appoint two directors.
- On June 13, 2022, Armistice irrevocably waived its appointment right under the July 2020 Purchase Agreement.
- The waiver eliminates Armistice's ability to designate future board members.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/0001654954-22-008452-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/34956/000165495422008452/tenx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-22-008452

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer